Clinical Trials

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06040320 2026-05-27

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Phase 1/2 Recruiting

12 enrolled

Lymphoma, Non-Hodgkin

NCT06458439 2026-05-27

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

31 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT06471296 2026-05-27

VIRONMENT

Recruiting

254 enrolled

Lymphoma, Virus Diseases

NCT06954805 2026-05-27

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

30 enrolled

Phase NA Not yet recruiting

Lymphoma, Lymphoproliferative Disorders, Lymphoma, B-Cell

NCT07249528 2026-05-27

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

Phase NA Recruiting

20 enrolled

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

10 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT07608978 2026-05-27

Pola-ZRCHP

35 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT07609030 2026-05-27

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Phase NA Recruiting

90 enrolled

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT07609446 2026-05-27

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

Not yet recruiting

30 enrolled

Phase 2 Active not recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT00846742 2026-05-26

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma

88 enrolled 21 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease

NCT03434730 2026-05-26

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Phase 2 Completed

46 enrolled 8 charts

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT03598998 2026-05-26

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

Phase 1/2 Active not recruiting

13 enrolled 12 charts

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT03820817 2026-05-26

Rifaximin in Patients With Monoclonal Gammopathy

Phase 1 Completed

50 enrolled

Waldenstrom Macroglobulinemia, Paraproteinemias

NCT04088864 2026-05-26

CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies

Phase 1 Completed

10 enrolled

Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04881240 2026-05-26

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04996706 2026-05-26

LEO

Enrolling by invitation

21,000 enrolled

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT05480449 2026-05-26

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Phase 1/2 Recruiting

115 enrolled

Burkitt Lymphoma

NCT07001384 2026-05-26

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

30 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Large-Cell, Anaplastic

NCT07052916 2026-05-26

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Phase NA Recruiting

60 enrolled

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07343934 2026-05-26

huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

6 enrolled

Lymphoma, Follicular, Recurrence

NCT00690560 2026-05-22

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Phase 2 Completed

30 enrolled 11 charts

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT01446133 2026-05-22

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

120 enrolled

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01476410 2026-05-22

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase 2 Completed

49 enrolled 25 charts

Phase 2 Active not recruiting

Hodgkin Disease

NCT02427620 2026-05-22

Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma

131 enrolled

Lymphoma, Mantle-Cell

NCT02443831 2026-05-22

CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02727803 2026-05-22

Personalized NK Cell Therapy in CBT

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

100 enrolled

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT03789097 2026-05-22

Vaccination With Flt3L, Radiation, and Poly-ICLC

Phase 1/2 Completed

17 enrolled

BreastHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT05616325 2026-05-22

FERTILymph

Recruiting

270 enrolled

Lymphoma, Lymphoma, Follicular

NCT05783609 2026-05-22

Epcoritamab and Rituximab for First-line Follicular Lymphoma

100 enrolled

Lymphoma, Follicular

NCT06651177 2026-05-22

TAB

310 enrolled

Lymphoma, Follicular, Opioid-Related Disorders

NCT06812858 2026-05-22

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

83 enrolled

Hodgkin Disease

NCT07008027 2026-05-22

Real World Asparaginase Therapy Toxicity

Not yet recruiting

200 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07223021 2026-05-22

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Phase 3 Recruiting

130 enrolled

Phase 1 Not yet recruiting

Burkitt Lymphoma

NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

14 enrolled

Phase NA Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07592481 2026-05-22

HEMO-CONNECT

40 enrolled

Hypertension, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07599033 2026-05-22

PAPE-MID

Phase NA Completed

46 enrolled

Phase 1/2 Not yet recruiting

Lymphoma, Follicular, Intellectual Disability, Motor Activity

NCT07601607 2026-05-22

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

51 enrolled

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT07604987 2026-05-22

R-PMDT Regimen in Newly Diagnosed PCNSL

33 enrolled